QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Expands Fujifilm Vet Systems Agreement to Develop Nu.Q Vet Feline Cancer Test in Japan
VolitionRx Limited (NYSE American: VNRX), a multinational epigenetics company, announced the expansion of its supply agreement with Fujifilm Vet Systems Co. Ltd. in Japan to include the development and use of its Nu.Q Vet Feline Test. The agreement builds on the July 2024 launch of the Nu.Q Vet Canine Test in Japan, where growing veterinary demand prompted the introduction of an automated version earlier this year. The expansion follows research demonstrating high accuracy for a prototype feline assay in detecting lymphoma, the most common cancer in cats. Fujifilm plans to conduct an additional study with veterinary oncologists in Japan. Volition…